# Transcriptome Analysis of BAFF/BAFF-R System in Murine Nephrotoxic Serum Nephritis

**Authors:** Tamara Möckel, Sebastian Boegel, Andreas Schwarting

PMC · DOI: 10.3390/ijms25105415 · International Journal of Molecular Sciences · 2024-05-16

## TL;DR

This study explores how the BAFF/BAFF-R system affects kidney disease progression in mice, finding that blocking BAFF may help reduce chronic kidney damage.

## Contribution

The study identifies specific genes influenced by BAFF signaling in CKD and suggests anti-BAFF drugs like belimumab could be a new treatment approach.

## Key findings

- BAFF signaling is directly linked to collagen III upregulation in kidney disease.
- BAFF knockout mice showed reduced collagen III expression, but not via BAFF-R.
- Genes like Txnip, Gpx3, and Igfbp7 are upregulated in chronic kidney injury due to BAFF.

## Abstract

Chronic kidney disease (CKD) is an emerging cause for morbidity and mortality worldwide. Acute kidney injury (AKI) can transition to CKD and finally to end-stage renal disease (ESRD). Targeted treatment is still unavailable. NF-κB signaling is associated with CKD and activated by B cell activating factor (BAFF) via BAFF-R binding. In turn, renal tubular epithelial cells (TECs) are critical for the progression of fibrosis and producing BAFF. Therefore, the direct involvement of the BAFF/BAFF-R system to the pathogenesis of CKD is conceivable. We performed non-accelerated nephrotoxic serum nephritis (NTN) as the CKD model in BAFF KO (B6.129S2-Tnfsf13btm1Msc/J), BAFF-R KO (B6(Cg)-Tnfrsf13ctm1Mass/J) and wildtype (C57BL/6J) mice to analyze the BAFF/BAFF-R system in anti-glomerular basement membrane (GBM) disease using high throughput RNA sequencing. We found that BAFF signaling is directly involved in the upregulation of collagen III as BAFF ko mice showed a reduced expression. However, these effects were not mediated via BAFF-R. We identified several upregulated genes that could explain the effects of BAFF in chronic kidney injury such as Txnip, Gpx3, Igfbp7, Ccn2, Kap, Umod and Ren1. Thus, we conclude that targeted treatment with anti-BAFF drugs such as belimumab may reduce chronic kidney damage. Furthermore, upregulated genes may be useful prognostic CKD biomarkers.

## Linked entities

- **Genes:** TXNIP (thioredoxin interacting protein) [NCBI Gene 10628], GPX3 (glutathione peroxidase 3) [NCBI Gene 2878], IGFBP7 (insulin like growth factor binding protein 7) [NCBI Gene 3490], CCN2 (cellular communication network factor 2) [NCBI Gene 1490], CDKN3 (cyclin dependent kinase inhibitor 3) [NCBI Gene 1033], UMOD (uromodulin) [NCBI Gene 7369], Ren1 (renin 1 structural) [NCBI Gene 19701]
- **Proteins:** TNFSF13B (TNF superfamily member 13b), TNFRSF13C (TNF receptor superfamily member 13C), NFKB1 (nuclear factor kappa B subunit 1)
- **Diseases:** chronic kidney disease (MONDO:0005300), acute kidney injury (MONDO:0002492), end-stage renal disease (MONDO:0004375)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, UMOD (uromodulin) [NCBI Gene 7369] {aka ADMCKD2, ADTKD1, FJHN, HNFJ, HNFJ1, MCKD2}, TNFRSF13C (TNF receptor superfamily member 13C) [NCBI Gene 115650] {aka BAFF-R, BAFFR, BROMIX, CD268, CVID4, prolixin}, GPX3 (glutathione peroxidase 3) [NCBI Gene 2878] {aka GPx-P, GSHPx-3, GSHPx-P}, CDKN3 (cyclin dependent kinase inhibitor 3) [NCBI Gene 1033] {aka CDI1, CIP2, KAP, KAP1}, TXNIP (thioredoxin interacting protein) [NCBI Gene 10628] {aka ARRDC6, EST01027, HHCPA78, THIF, VDUP1}, IGFBP7 (insulin like growth factor binding protein 7) [NCBI Gene 3490] {aka AGM, FSTL2, IBP-7, IGFBP-7, IGFBP-7v, IGFBPRP1}, TNFSF13B (TNF superfamily member 13b) [NCBI Gene 10673] {aka BAFF, BLYS, CD257, TALL-1, TALL1, THANK}, CCN2 (cellular communication network factor 2) [NCBI Gene 1490] {aka CTGF, HCS24, IBP-8, IGFBP8, KMD, NOV2}
- **Diseases:** AKI (MESH:D058186), ESRD (MESH:D007676), kidney injury (MESH:D007674), fibrosis (MESH:D005355), NTN (MESH:D009393), anti-glomerular basement membrane (GBM) disease (MESH:D019867), CKD (MESH:D051436)
- **Chemicals:** belimumab (MESH:C511911)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** B6 — Homo sapiens (Human), Finite cell line (CVCL_L814)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11121395/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11121395/full.md

## References

110 references — full list in the complete paper: https://tomesphere.com/paper/PMC11121395/full.md

---
Source: https://tomesphere.com/paper/PMC11121395